Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

Vance Thompson Vision

Overview

The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).

Study Type

OBSERVATIONAL

Conditions

Cataract Pseudophakia

Interventions

Data collectionOTHER

Collection of clinical data from groups of patients already implanted with the light adjustable lens (LAL) and have completed light treatments.

Eligibility

Sex: ALLMin age: 40 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Sign a written Informed Consent Document * Implanted commercially with the LAL and completed LDD light treatments Exclusion Criteria: * Previous corneal or intraocular surgery other than removal of cataract and implantation of the LAL

Locations (1)

Vance Thompson Vision

Sioux Falls, South Dakota, United States

Outcomes

Primary Outcomes

Manifest refraction

A qualified ophthalmologist, optometrist, or a trained ophthalmic technician should obtain the refraction, in 0.25D steps, in a calibrated refraction lane. If the subject has a current pair of glasses for distance vision, they can be measured with a lensometer, and these measurements are used as the beginning approximate refraction

Time frame: Pre operatively and immediately post operatively

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.